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Impacts of duration of untreated psychosis on
cognition and negative symptoms in ﬁrst-episode
schizophrenia: a 3-year prospective follow-up study
W. C. Chang*, C. L. M. Hui, J. Y. M. Tang, G. H. Y. Wong, S. K. W. Chan, E. H. M. Lee
and E. Y. H. Chen
Department of Psychiatry, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong
Background. Cognitive impairment is a core feature of schizophrenia. Its relationship with duration of untreated
psychosis (DUP), a potentially malleable prognostic factor, has been less studied, with inconsistent ﬁndings being
observed in the literature. Previous research investigating such a relationship was mostly cross-sectional and none of
those prospective studies had a follow-up duration beyond 2 years.
Method. A total of 93 Hong Kong Chinese aged 18 to 55 years presenting with ﬁrst-episode schizophrenia-spectrum
disorder were studied. DUP and pre-morbid adjustment were measured using a structured interview incorporating
multiple sources of information. Psychopathological evaluation was administered at intake, after clinical stabilization
of the ﬁrst psychotic episode, and at 12, 24 and 36 months. Cognitive functions were measured at clinical
stabilization, and at 12, 24 and 36 months.
Results. DUP exerted diﬀerential eﬀects on various cognitive domains, with memory deﬁcits being the most related
to DUP even when potential confounders including pre-morbid adjustment and sex were adjusted. Prolonged DUP
was associated with more severe impairment in visual memory at clinical stabilization and verbal memory at 24 and
36 months. Further, patients with a long DUP were found to have worse outcomes on negative symptoms at
36 months. The eﬀects of DUP on verbal memory remained signiﬁcant even when negative symptoms were taken
into consideration.
Conclusions. Our ﬁndings provided further supportive evidence that delayed treatment to ﬁrst-episode psychosis is
associated with poorer cognitive and clinical outcomes. In addition, DUP may speciﬁcally aﬀect memory function
and its adverse impact on verbal memory may only become evident at a later stage of the recovery process.
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symptoms, prospective follow-up.
Introduction
Duration of untreated psychosis (DUP) has been con-
sidered as a potentially modiﬁable prognostic factor
of schizophrenia. The majority of studies examining
DUP have focused on its relationships with clinical
and functional outcomes, and they revealed that pro-
longed DUP predicts a higher level of symptoms,
worse psychosocial functioning and poorer quality of
life (Marshall et al. 2005 ; Perkins et al. 2005).
Cognitive impairment is a core feature of schizo-
phrenia (Elvevag & Goldberg, 2000). A substantial
body of evidence has demonstrated that patients
presenting with ﬁrst-episode schizophrenia exhibit
pronounced deﬁcits across various cognitive domains,
particularly in memory, attention and executive func-
tion (Mesholam-Gately et al. 2009). As cognitive dys-
function has consistently been shown to predict
functional disability (Green et al. 2000) and remains an
unmet therapeutic need due to its limited response
to antipsychotic treatment (Goldberg et al. 2007),
clariﬁcations of correlates associated with cognitive
impairment, in particular those being potentially mal-
leable to interventions such as DUP, are of signiﬁcant
clinical relevance. Nonetheless, relatively few studies
have been conducted to investigate the relationship
between DUP and cognitive functions in schizo-
phrenia. Among those few studies, some have in-
dicated that prolonged DUP is related to more severe
cognitive impairment (Scully et al. 1997 ; Amminger
et al. 2002 ; Joyce et al. 2002 ; Lappin et al. 2007), while
others have failed to ﬁnd such a relationship (Hoﬀ et al.
2000 ; Norman et al. 2001 ; Townsend et al. 2002 ; Ho et al.
2003 ; Addington et al. 2004 ; Rund et al. 2007 ; Barnes
et al. 2008 ; Goldberg et al. 2009).
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Inconsistency in ﬁndings regarding the association
between DUP and cognitive functions in schizo-
phrenia may partly be attributed to methodological
variations in sampling, measurements of DUP and
outcome variables, choice of cognitive assessments
administered, and lengths of follow-up. Of note, cog-
nitive performance may change substantially from
treatment initiation to the time when psychosis
has been stabilized (Townsend et al. 2002). In addition,
certain cognitive functions may improve over a
longer period of time after the initial psychotic episode
(Gold et al. 1999 ; Albus et al. 2002). On the other hand,
most previous studies that addressed the relationship
between DUP and cognitive functions were cross-
sectional with focus on initial presentation of the ﬁrst
psychotic episode (Hoﬀ et al. 2000 ; Norman et al. 2001 ;
Amminger et al. 2002 ; Joyce et al. 2002 ; Ho et al. 2003 ;
Lappin et al. 2007). For those very few prospective
longitudinal studies, their lengths of follow-up ranged
from 4 months to 2 years only (Townsend et al. 2002 ;
Addington et al. 2004 ; Rund et al. 2007 ; Barnes et al.
2008 ; Goldberg et al. 2009). In this regard, studies with
such a short follow-up interval may fail to capture an
evolving course of cognitive recovery, and hence its
association with DUP in the early phase of the illness.
Discrepant ﬁndings have also been observed with
respect to the relationship between DUP and negative
symptoms. Whereas several past studies (Scully et al.
1997 ; Harrigan et al. 2003 ; Melle et al. 2008) and two
meta-analyses (Marshall et al. 2005; Perkins et al. 2005)
found that longer DUP predicted worse outcome on
negative symptoms, other investigators revealed a
lack of independent contribution of DUP on severity
of negative symptoms when pre-morbid adjustment
was taken into consideration (Harris et al. 2005 ;
Jeppesen et al. 2008).
In this article, we present a prospective 3-year
follow-up study in a representative cohort of Chinese
patients having ﬁrst-episode schizophrenia-spectrum
disorder in Hong Kong with an aim to examine the
inﬂuence of DUP on longitudinal trajectories of cogni-
tive and clinical measures. DUP was measured using
a standardized instrument incorporating multiple
sources of information when patients ﬁrst presented to
treatment. The potential confounding eﬀects of pre-
morbid functioning on cognitive and clinical outcomes
were adjusted to enable a better estimation of a unique
contribution of DUP to these outcome measures.
Method
Participants
Participants were recruited from both out-patient and
in-patient psychiatric units that provide service for a
catchment area in Hong Kong with a population of
approximately 1.3 million. A total of 138 patients aged
18–55 years who were consecutively diagnosed as
having ﬁrst-episode schizophrenia, schizophreniform
disorder or schizo-aﬀective disorder were included.
Patients with known neurological disorder or learning
disability were excluded from the study. Of the initial
cohort, 93 subjects completed the 3-year follow-up,
40 defaulted, four committed suicide and one died of
medical disease. There were no signiﬁcant diﬀerences
between completers and non-completers in socio-
demographics, DUP, baseline symptom ratings and
cognitive functions. Patients in this study were
initially treated with low-dose ﬁrst-generation anti-
psychotic medications. Among 93 subjects, 48 were
ﬁrst assessed in a medication-naive state, and the rest
were evaluated within 7 days of starting antipsychotic
treatment.
The current study was part of a prospective 3-year
follow-up study in ﬁrst-episode schizophrenia-
spectrum disorder patients and ﬁndings regarding
persistent negative symptoms and cognitive pre-
dictors of relapse have been reported elsewhere (Chen
et al. 2005 ; Chang et al. 2011). The study was approved
by the local institutional review board and all of
the subjects gave written informed consent before
participation.
Diagnostic, clinical and cognitive assessments
Diagnostic assignment was based on a longitudinal
approach taking into consideration that diagnostic
change may take place over time (Chang et al. 2009).
The 3-year diagnosis of each subject was determined
according to Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV) criteria
(APA, 1994) using all available information encom-
passing the whole follow-up period including the
Chinese-bilingual Structured Clinical Interview for
DSM-IV (Axis I, Patient version) (CB-SCID-I/P, So
et al. 2003) administered at baseline and at 3 years,
informant histories and medical records. A previous
validation study showed that the CB-SCID-I/P yields
reliable DSM-IV diagnoses in Chinese patients with
psychotic disorders (So et al. 2003). Independent di-
agnostic assessments on a subset of the sample (n=38)
demonstrated a satisfactory concordance rate of 86%.
Pre-morbid functioning was measured with the
Premorbid Adjustment Scale (PAS; Cannon-Spoor
et al. 1982) based on information obtained via inter-
views with patients and relatives. We only included
childhood (f11 years) and early adolescence
(12–15 years) periods for assessment to avoid any
possible confounding with early symptoms because
the onset of prodrome and psychosis usually occurs in
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late adolescence and early adulthood (Cassidy et al.
2010). The PAS total score was calculated by summing
the scores on all items encompassing both childhood
and early adolescence periods and dividing by the to-
tal possible score (score range 0 to 1; a higher score
indicates lower functioning).
DUP, which was deﬁned as the time interval be-
tween the onset of positive psychotic symptoms and
treatment initiation, was assessed with the Interview
for the Retrospective Assessment of the Onset of
Schizophrenia (Ha¨fner et al. 1992) incorporating in-
formation from patients, relatives and medical re-
cords. Positive symptoms were assessed using the
Positive and Negative Syndrome Scale (PANSS; Kay
et al. 1987) with intra-class correlation coeﬃcient (ICC)
being 0.83 for the positive symptoms subscale. The
High Royds Evaluation of Negativity Scale (HEN;
Mortimer et al. 1989) was employed to measure nega-
tive symptoms. It comprises six subscales and 18 items
that are rated along an anchored ﬁve-point severity
scale (range 0–4; a higher score indicates more severe
negative symptoms). Validation of the HEN for use
in Chinese schizophrenia patients has previously
been reported (Chen et al. 1996). ICCs for the subscales
ranged from 0.74 (Thought) to 0.85 (Speech). In this
study, we only included four of the six subscales, i.e.
Aﬀect, Behaviour, Speech and Functioning subscales
for analysis (Chang et al. 2011) as the remaining two,
namely Thought and Appearance subscales, were
more related to the disorganization dimension.
A comprehensive battery of cognitive assessments
was administered to all subjects, comprising a logical
memory test (Wechsler Memory Scale Revised; WMS-
R-HK, Hong Kong Psychological Society, 1989b), a
visual reproduction test (WMS-R-HK), forward digit
span (Wechsler Adult Intelligence Scale ; WAIS-R-HK;
Hong Kong Psychological Society, 1989a), semantic
category ﬂuency and the Modiﬁed Wisconsin Card
Sorting Test (Nelson, 1976). General verbal intelligence
was estimated at baseline using the information sub-
scale from the WAIS-R-HK (Chen et al. 2005).
Psychopathological evaluation was conducted for
each subject at intake, after clinical stabilization of
the ﬁrst psychotic episode (a mean of 42.6 days after
initial assessment), and at 12, 24 and 36 months.
To maximize cooperation and to reduce state eﬀects of
acute psychosis, the cognitive assessment undertaken
when patients were clinically stabilized was regarded
as the baseline cognitive measure. The cognitive as-
sessment was re-administered to each subject at 12,
24 and 36 months. A group of healthy controls, mat-
ched for age, sex and educational level, were recruited
via advertisements and were evaluated with the same
battery of cognitive assessments as patients at base-
line only. Research staﬀ who administered symptom
and cognitive assessments was blind to the DUP
measure.
Statistical analysis
Diﬀerences between patients and matched controls
on baseline cognitive functions were evaluated using
the independent t test. The patient sample was div-
ided into short and long DUP groups based onmedian
split at 180 days. Pre-morbid functioning, and socio-
demographic and treatment characteristics between
the two groups were compared using the independent
t test and x2 test as appropriate. To compare symptom
and cognitive outcomes between the two groups at
each assessment time point, an analysis of covariance
(ANCOVA) was performed with sex and PAS total
score as covariates. Longitudinal changes in symptom
ratings and cognitive deﬁcits over 3 years were com-
pared between the two DUP groups using a repeated-
measures ANCOVA with time points as the within-
subject level, and sex and PAS total score as covariates.
The Greenhouse–Geisser correction was used when
the sphericity assumption was not met. All analyses
were two-tailed and the level of signiﬁcance was set at
p<0.05.
Results
Characteristics of the sample
Of the 93 subjects who were followed up for 3 years,
84 completed DUP assessments and thus constituted
the ﬁnal sample of the study. The 84 subjects were
predominantly single (72.6%), and 42.9% were male.
The mean age of the sample at intake was 31.5 years
(S.D.=9.5, range 18–55 years) and the average edu-
cational level was 10.49 years (S.D.=3.0). The median
DUP of the sample was 180 days and the mean was
473.7 days (S.D.=786.4, range 2–3650 days). Diagnoses
for the cohort were schizophrenia (n=67), schizo-
phreniform disorder (n=12) and schizo-aﬀective dis-
order (n=5). There were no signiﬁcant diﬀerences
between subjects with a DUP measure and those
without in sociodemographics, pre-morbid function-
ing, baseline symptom and cognitive measures, and
treatment characteristics.
Table 1 summarizes sociodemographics, pre-
morbid adjustment and treatment characteristics of the
patient sample. Patients with a long DUP were signiﬁ-
cantly more likely to be male than those with a short
DUP.Otherwise, no signiﬁcant diﬀerences between the
two groups among other variables were observed.
As shown in Table 2, there were no signiﬁcant dif-
ferences between patients and healthy controls in
age, sex and educational level. Patients performed
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signiﬁcantly worse than controls in all cognitive tests,
with a range from 0.4 (forward digit span) to 1.0
(logical memory, delayed recall) standard deviations
below those of controls with the exception of the visual
reproduction test which yielded no signiﬁcant diﬀer-
ences between the two groups. Thus, our results were
comparable with the ﬁndings in the literature on cog-
nitive impairment in patients presenting with ﬁrst-
episode schizophrenia (Mesholam-Gately et al. 2009).
Comparison between short and long DUP groups at
each assessment time point
As the long DUP group was found to be signiﬁcantly
associated with male sex in the current analysis, while
pre-morbid adjustment was shown by previous
studies to be related to the severity of negative symp-
toms (Harris et al. 2005 ; Jeppesen et al. 2009) and cog-
nitive impairment (Silverstein et al. 2002), a series of
ANCOVAs were performed with sex and pre-morbid
functioning as covariates to control their potential
confounding eﬀects on clinical and cognitive out-
comes.
Symptom outcomes
The long DUP group had signiﬁcantly more negative
symptoms than the short DUP group at the end of
the 3-year follow-up (F1,78=4.1, p<0.05). There were
no signiﬁcant diﬀerences in negative symptom levels
Table 1. Demographics, pre-morbid adjustment, baseline and treatment characteristics of patients with ﬁrst-episode schizophrenia-
spectrum disorder
Variable of interest
Subjects with DUP
<180 days (n=41)
Subjects with DUP
o180 days (n=43)
Statistics : x2
or t (df) p
Baseline sociodemographic and clinical characteristics
Mean age at entry, years (S.D.) 31.5 (10.2) 31.5 (8.9) x0.023 (82) 0.98
Male sex, n (%) 13 (31.7) 23 (53.5) 4.1 0.044
Mean duration of education, years (S.D.) 10.5 (3.6) 10.5 (2.4) x0.001 (82) 0.99
Mean PAS total score (S.D.) 0.34 (0.1) 0.36 (0.1) x0.4 (78) 0.67
Mean DUP, days (S.D.) 49 (42.7) 878.6 (936.1) 5.8 (82) <0.0001
Treatment characteristics
Mean CPZ equivalence at intake, mg/day (S.D.) 219.4 (615.4) 139.3 (195.5) 0.8 (82) 0.42
Mean CPZ equivalence at clinical stabilization, mg/day (S.D.) 405.4 (427.9) 304.9 (317.6) 1.2 (82) 0.22
Mean CPZ equivalence at year 1, mg/day (S.D.) 264.3 (391.6) 274.8 (242.5) 0.2 (82) 0.88
Mean CPZ equivalence at year 2, mg/day (S.D.) 293.9 (452.9) 245.0 (249.7) 0.6 (82) 0.54
Mean CPZ equivalence at year 3, mg/day (S.D.) 233.3 (346.4) 228.8 (233.8) 0.07 (82) 0.94
Mean anticholinergic dosea at intake, mg/day (S.D.) 0.7 (1.7) 1.2 (2.1) x1.3 (82) 0.21
Mean anticholinergic dosea at clinical
stabilization, mg/day (S.D.)
3.2 (3.4) 3.6 (3.5) x0.6 (82) 0.55
Mean anticholinergic dosea at year 1, mg/day (S.D.) 2.2 (2.9) 2.9 (2.8) x1.1 (82) 0.29
Mean anticholinergic dosea at year 2, mg/day (S.D.) 2.1 (2.9) 2.1 (2.5) x0.08 (82) 0.94
Mean anticholinergic dosea at year 3, mg/day (S.D.) 2.2 (2.8) 2.0 (2.6) 0.4 (82) 0.68
On SGA at clinical stabilizationb,c, n (%) 1 (2.4) 1 (2.3) 0.001 0.99
On SGA at year 1b,d, n (%) 4 (9.8) 3 (7.0) 0.2 0.71
On SGA at year 2b,e, n (%) 5 (12.2) 8 (18.6) 0.7 0.55
On SGA at year 3b,f, n (%) 7 (17.1) 8 (18.6) 0.3 0.86
DUP, Duration of untreated psychosis ; df, degrees of freedom; S.D., standard deviation ; PAS, Premorbid Adjustment Scale ;
CPZ, chlorpromazine ; SGA, second-generation antipsychotic ; FGA, ﬁrst-generation antipsychotic.
a Anticholinergic medication refers to benzhexol.
b Fisher’s exact test was applied.
c Out of the 84 subjects, two took SGAmedication at clinical stabilization, with all on risperidone. The remaining subjects were
treated with a FGA.
dOut of the 84 subjects, seven took SGA medication at year 1, with ﬁve on risperidone and two on olanzapine. The remaining
subjects were treated with FGA medication.
e Out of the 84 subjects, 13 took SGA medication at year 2, with 10 on risperidone, two on olanzapine and one on clozapine.
The remaining subjects were treated with FGA medication.
f Out of the 84 subjects, 15 took SGA medication at year 3, with 11 on risperidone, three on olanzapine and one on clozapine.
The remaining subjects were treated with FGA medication.
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between the two groups at other time points although
there was a trend indicating that patients with a long
DUP exhibited a worse outcome on negative symp-
toms from 12 months onwards compared with those
with a short DUP. The two groups did not diﬀer in the
severity of positive symptoms at all time points
(Table 3).
Cognitive outcomes
There were no signiﬁcant diﬀerences between the
two groups in baseline cognitive measures with the
exception that the short DUP group outperformed
the long DUP group in the visual reproduction test
(delayed recall) (F1,76=60.3, p<0.05). Subjects with a
Table 2. Comparison of sociodemographics and baseline cognitive functions between patients and healthy controls
Variable of interest
Patients
(n=93)
Controls
(n=114)
Statistics :
x2 or t (df) p
Sociodemographic characteristics
Mean age at entry, years (S.D.) 31.2 (9.6) 33.4 (10.0) 1.6 (205) 0.11
Male sex, n (%) 42 (45.2) 47 (41.2) 0.3 0.57
Mean duration of education, years (S.D.) 10.5 (2.9) 11.1 (2.2) 1.6 (205) 0.11
Baseline cognitive functions
Mean WAIS-R-HK information subset (S.D.) 14.6 (5.4) 17.1 (4.7) 3.5 (205) 0.001
Mean WAIS-R-HK digit span forward (S.D.) 11.4 (1.9) 12.1 (1.7) 2.5 (205) 0.013
Mean WMS-R-HK logical memory, immediate recall (S.D.) 35.1 (17.0) 50.6 (18.9) 6.1 (205) <0.0001
Mean WMS-R-HK logical memory, delayed recall (S.D.) 28.3 (17.5) 45.2 (19.6) 6.4 (205) <0.0001
Mean WMS-HK visual reproduction, immediate recall (S.D.) 20.2 (3.4) 20.7 (3.2) 1.2 (205) 0.232
Mean WMS-HK visual reproduction, delayed recall (S.D.) 19.6 (3.7) 19.9 (4.1) 0.7 (205) 0.203
Mean semantic category ﬂuency (S.D.) 17.0 (4.6) 20.0 (5.8) 4.0 (205) <0.0001
Mean MWCST categories completed (S.D.) 4.1 (2.2) 5.0 (1.5) 3.5 (204) 0.001
Mean MWCST perseverative errors (S.D.) 6.0 (7.9) 3.3 (3.4) x2.9 (204) 0.005
df, Degrees of freedom; S.D., standard deviation ; WAIS-R-HK, Wechsler Adult Intelligence Scale Revised (Hong Kong
version) ; WMS-R-HK, Wechsler Memory Scale Revised (Hong Kong version) ; MWCST, Modiﬁed Wisconsin Card Sorting Test.
Table 3. Symptom ratings of patients with ﬁrst-episode schizophrenia-spectrum disorder
across 3 years of follow-upa
Assessment time
point
Patients categorized as
short v. long DUP group
PANSS positive
symptom score
HEN total
score
Intake evaluation DUP<180 days 20 (6.2) 12.2 (11.5)
DUPo180 days 19.8 (4.7) 14.6 (11.8)
Clinical stabilization DUP<180 days 9.0 (2.5) 10.8 (9.9)
DUPo180 days 9.4 (2.7) 10.7 (9.4)
Year 1 assessment DUP<180 days 8.7 (3.6) 8.5 (8.6)
DUPo180 days 9.3 (3.1) 12.8 (10.5)
Year 2 assessment DUP<180 days 8.8 (3.1) 10.0 (10.9)
DUPo180 days 9.1 (3.3) 13.3 (11.2)
Year 3 assessment DUP<180 days 8.9 (3.9) 7.7 (10.0)
DUPo180 days 9.3 (3.0) 12.0 (13.1)*
DUP, Duration of untreated psychosis ; PANSS, Positive and Negative Syndrome
Scale ; HEN, High Royds Evaluation of Negativity Scale.
Data are given as mean (standard deviation).
a Analysis of covariance was conducted with sex and Premorbid Adjustment Scale
total score as covariates.
* p<0.05.
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short DUP scored signiﬁcantly higher in the logical
memory test (both immediate and delayed recall)
than those with a long DUP at 24 months (immediate
recall : F1,77=12.5, p=0.001; delayed recall : F1,77=13.5,
p<0.001) and 36 months (immediate recall : F1,77=11.0,
p=0.001 ; delayed recall : F1,77=13.3, p=0.001). No
signiﬁcant diﬀerences were found in other cognitive
measures at subsequent follow-ups (Table 4).
Comparison between short and long DUP groups
across the 3-year follow-up period
Symptom outcomes
Results from a repeated-measures ANCOVA, control-
ling for the eﬀects of sex and pre-morbid adjustment,
showed that the main between-subject eﬀect of DUP
on negative symptoms was signiﬁcant (F1,73=4.2,
p<0.05). This indicates that the short DUP group had
fewer negative symptoms than the long DUP group
across the 3-year follow-up period. The within-subject
eﬀect and timergroup interaction did not reach stat-
istical signiﬁcance. No signiﬁcant results were found
for positive symptom scores for all main eﬀect and
interaction analyses.
Cognitive outcomes
The longitudinal analysis revealed a signiﬁcant main
between-subject eﬀect of DUP on both immediate and
delayed recall of logical memory (immediate recall :
F1,71=7.4, p<0.05 ; delayed recall : F1,71=8.5, p<0.05).
The results thus suggest that the short DUP group
scored higher than the long DUP group in both im-
mediate and delayed recall of logical memory across
all time points. The interactions between DUP and
logical memory were signiﬁcant (immediate recall :
F3,213=3.6, p<0.01 ; delayed recall : F2.7,190.9=4.4,
p<0.01), with the within-subject contrast test showing
a signiﬁcant change between 12 and 24 months after
intake assessment (immediate recall : F1,71=12.4, p=
0.001 ; delayed recall : F1,71=15.4, p<0.001). There was
no signiﬁcant within-subject eﬀect of logical memory
observed. No signiﬁcant main between-subject eﬀect
of DUP on other cognitive measures or grouprtime
interaction eﬀect was found.
Impact of DUP on cognition when negative
symptoms were taken into consideration
As our results indicated that DUP was signiﬁcantly
associated with the severity of both negative symp-
toms and logical memory impairment at 36 months,
and the literature suggested that cognitive functions
were correlated with negative symptoms in schizo-
phrenia particularly on a cross-sectional basis (HarveyT
ab
le
4.
S
co
re
s
on
co
gn
it
iv
e
m
ea
su
re
s
of
pa
ti
en
ts
w
it
h
ﬁ
rs
t-
ep
is
od
e
sc
hi
zo
ph
re
n
ia
-s
pe
ct
ru
m
di
so
rd
er
ac
ro
ss
3
ye
ar
s
of
fo
ll
ow
-u
p
C
o
g
n
it
iv
e
fu
n
ct
io
n
a
C
li
n
ic
al
st
ab
il
iz
at
io
n
Y
ea
r
1
Y
ea
r
2
Y
ea
r
3
D
U
P
<
18
0
d
ay
s
D
U
P
o
18
0
d
ay
s
D
U
P
<
18
0
d
ay
s
D
U
P
o
18
0
d
ay
s
D
U
P
<
18
0
d
ay
s
D
U
P
o
18
0
d
ay
s
D
U
P
<
18
0
d
ay
s
D
U
P
o
18
0
d
ay
s
In
fo
rm
at
io
n
su
b
se
t
14
.5
(5
.8
)
14
.9
(5
.2
)
D
ig
it
sp
an
fo
rw
ar
d
11
.5
(2
.2
)
11
.4
(1
.9
)
12
.1
(2
.3
)
12
.1
(1
.4
)
12
.0
(2
.0
)
12
.1
(1
.4
)
11
.7
(2
.2
)
12
.2
(1
.3
)
L
o
g
ic
al
m
em
o
ry
,
im
m
ed
ia
te
re
ca
ll
39
.0
(1
7.
0)
32
.7
(1
7.
2)
37
.2
(1
6.
0)
34
.7
(1
6.
1)
42
.5
(1
6.
0)
31
.8
(1
6.
2)
**
45
.1
(1
7.
3)
35
.3
(1
4.
6)
**
L
o
g
ic
al
m
em
o
ry
,
d
el
ay
ed
re
ca
ll
32
.4
(1
8.
0)
25
.4
(1
6.
6)
33
.0
(1
6.
6)
29
.7
(1
4.
4)
38
.1
(1
7.
9)
26
.4
(1
6.
8)
**
*
42
.8
(1
7.
8)
30
.7
(1
6.
7)
**
V
is
u
al
re
p
ro
d
u
ct
io
n
,
im
m
ed
ia
te
re
ca
ll
20
.8
(3
.3
)
19
.5
(3
.7
)
20
.6
(3
.8
)
19
.6
(3
.4
)
20
.4
(3
.6
)
19
.3
(3
.2
)
21
.3
(3
.8
)
20
.6
(2
.8
)
V
is
u
al
re
p
ro
d
u
ct
io
n
,
d
el
ay
ed
re
ca
ll
20
.5
(3
.0
)
18
.8
(4
.1
)*
20
.3
(3
.4
)
18
.8
(3
.5
)
20
.4
(3
.9
)
19
.3
(2
.9
)
21
.2
(3
.8
)
20
.5
(2
.7
)
S
em
an
ti
c
ca
te
g
o
ry
ﬂ
u
en
cy
17
.2
(4
.4
)
17
.2
(4
.8
)
17
.9
(5
.1
)
17
.3
(5
.1
)
18
.2
(6
.5
)
17
.7
(5
.1
)
18
.6
(5
.7
)
18
.0
(4
.8
)
M
W
C
S
T
ca
te
g
o
ri
es
co
m
p
le
te
d
4.
5
(2
.1
)
4.
1
(1
.9
)
5.
2
(1
.8
)
5.
1
(1
.5
)
5.
3
(1
.7
)
5.
2
(1
.8
)
5.
3
(1
.8
)
5.
4
(1
.4
)
M
W
C
S
T
p
er
se
v
er
at
iv
e
er
ro
rs
4.
3
(4
.8
)
5.
0
(6
.2
)
1.
7
(2
.2
)
3.
0
(4
.7
)
1.
6
(3
.2
)
3.
0
(6
.9
)
1.
1
(2
.5
)
1.
8
(4
.6
)
D
U
P
,
D
u
ra
ti
o
n
o
f
u
n
tr
ea
te
d
p
sy
ch
o
si
s
;
M
W
C
S
T
,
M
o
d
iﬁ
ed
W
is
co
n
si
n
C
ar
d
S
o
rt
in
g
T
es
t.
D
at
a
ar
e
g
iv
en
as
m
ea
n
(s
ta
n
d
ar
d
d
ev
ia
ti
o
n
).
a
A
n
al
y
si
s
o
f
co
v
ar
ia
n
ce
w
as
co
n
d
u
ct
ed
w
it
h
se
x
an
d
P
re
m
o
rb
id
A
d
ju
st
m
en
t
S
ca
le
to
ta
l
sc
o
re
as
co
v
ar
ia
te
s.
*
p<
0.
05
,
**
p<
0.
01
,
**
*
p<
0.
00
1.
1888 W. C. Chang et al.
et al. 2006), Pearson correlation analysis was thus
conducted to examine the relationship between
logical memory and negative symptoms at 36 months.
Negative symptom level was found to be signiﬁcantly
correlated to both immediate (r=x0.35, p=0.001) and
delayed (r=x0.36, p<0.001) recall of logical memory.
To control for the potential confounding eﬀect of
negative symptoms on memory functions, we re-
peated cross-sectional (ANCOVA at 36 months) and
longitudinal (repeated-measures ANCOVA) analyses
with logical memory as the dependent variable and
negative symptom rating at 36 months as a covariate
along with sex and pre-morbid adjustment. The short
DUP group was found to perform signiﬁcantly better
than the long DUP group in logical memory at the end
of the 3-year follow-up (immediate recall : F1,77=7.7,
p<0.01 ; delayed recall : F1,77=9.7, p<0.01). Repeated-
measures ANCOVA revealed a signiﬁcant main be-
tween-subject eﬀect of DUP on logical memory
(immediate recall : F1,71=4.2, p<0.05 ; delayed recall :
F1,71=5.2, p<0.05) and signiﬁcant grouprtime inter-
actions (immediate recall : F3,207=3.9, p<0.01 ; delayed
recall : F2.7,185.2=4.3, p<0.01) with signiﬁcant change
lying between 12 and 24 months after intake assess-
ment. Thus, associations between DUP and logical
memory remained signiﬁcant even when negative
symptoms were taken into consideration.
Discussion
The aim of the present study was to evaluate pro-
spectively the impact of DUP on clinical and cognitive
outcomes in patients presenting with ﬁrst-episode
schizophrenia. Our ﬁndings indicated that patients
with a short DUP showed fewer negative symptoms
and more improvement in verbal memory over the
3-year follow-up period.
While the literature mostly suggests a lack of an
association between DUP and negative symptoms
at initial presentation in patients experiencing ﬁrst-
episode schizophrenia (Addington et al. 2004 ; Harris
et al. 2005 ; Jeppesen et al. 2009), results with regard to
the impact of DUP on negative symptoms at follow-up
are less consistent. Some investigators have posited
that the observed relationship between DUP and
negative symptoms may be partly spurious and con-
founded by pre-morbid functioning which has been
shown to predict the severity of negative symptoms
(Harris et al. 2005 ; Jeppesen et al. 2009). Our results,
which are in agreement with two meta-analyses
(Marshall et al. 2005 ; Perkins et al. 2005) and several
past reports (Scully et al. 1997 ; Harrigan et al. 2003 ;
Melle et al. 2008), showed that DUP predicts outcome
on negative symptoms when the eﬀect of pre-morbid
adjustment is adjusted. Further, our ﬁndings revealed
diﬀerential trajectories of negative symptoms in two
DUP groups. We found similar levels of negative
symptoms between the two groups at intake and at the
time when their ﬁrst psychotic episodes were stabi-
lized with treatment. However, by the end of the ﬁrst
year of follow-up, there was a trend suggesting a fur-
ther decrease in negative symptoms in the short DUP
group and an accumulation of negative symptoms in
the long DUP group, with diﬀerence in symptom se-
verity between the two groups reaching signiﬁcance
at the end of the 3-year follow-up. Thus, our results
provide further support to an independent contri-
bution of DUP to clinical outcome in which schizo-
phrenia patients with longer DUP tend to exhibit an
accrual of negative symptoms over the initial 3 years
after treatment initiation. In fact, some researchers
have suggested that a prolonged DUP may predict the
subsequent development of persistent negative
symptoms (Edwards et al. 2002 ; Malla et al. 2004).
Consistent with previous studies (Mesholam-Gately
et al. 2009), our results showed that patients with ﬁrst-
episode schizophrenia had prominent cognitive im-
pairment at baseline when compared with healthy
controls. In line with most (Hoﬀ et al. 2000 ; Norman
et al. 2001 ; Ho et al. 2003 ; Addington et al. 2004), but
not all prior reports (Joyce et al. 2002 ; Lappin et al.
2007), we found no signiﬁcant association between
DUP and most baseline cognitive functions. Two in-
triguing ﬁndings emerged in this study regarding the
impact of DUP on longitudinal cognitive outcomes.
First, among various cognitive functions, patients with
a longer DUP were signiﬁcantly more impaired in two
speciﬁc areas, namely verbal and visual memory.
Second, the eﬀects of DUP on temporal evolution of
these two memory deﬁcits were diﬀerent. A signiﬁ-
cant diﬀerence between the short and long DUP
groups on visual memory was observed only at the
time of clinical stabilization, with the former out-
performing the latter. Conversely, patients with a
longer DUP were found to have greater verbal mem-
ory impairment than those with a short DUP at the
end of the second and the third years of follow-up.
Thus, our ﬁndings indicate that among various cog-
nitive domains, DUP may have a speciﬁc eﬀect
on memory function. In addition, DUP may impose
short-term adverse eﬀects on visual memory in the
early phase of recovery from the ﬁrst psychotic epi-
sode, while it may cause longer-term eﬀects on verbal
memory at a later stage of the recovery process. In this
regard, our results were consistent with some earlier
studies (Scully et al. 1997 ; Amminger et al. 2002) that
prolonged DUP was related to worse cognitive out-
comes.
It is important to note that thus far very few pro-
spective ﬁrst-episode studies have been conducted to
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examine the inﬂuence of DUP on longitudinal cogni-
tive outcomes, and, contrary to our results, most failed
to ﬁnd an inverse relationship between DUP and cog-
nitive functions at follow-up (Townsend et al. 2002 ;
Addington et al. 2004 ; Rund et al. 2007 ; Barnes et al.
2008 ; Goldberg et al. 2009). One possible reason for
such discrepancy may relate to the timing of assess-
ments and length of follow-up. Those few studies that
revealed negative ﬁndings had a duration of follow-
up that ranged from 4 months to 2 years only
(Townsend et al. 2002 ; Addington et al. 2004 ; Rund
et al. 2007 ; Barnes et al. 2008 ; Goldberg et al. 2009). In
fact, their ﬁndings of no signiﬁcant relationship be-
tween DUP and cognitive impairment at 1 year after
treatment initiation were replicated by our study.
Thus, it raises the possibility that previous research
with short study periods may fail to detect the impact
of DUP on cognitive function as such a relationship
may become more evident only with a longer duration
of follow-up. The inconsistent ﬁndings may also be
attributable to the variation of diagnostic scope
and DUP of the samples studied. In particular, for
those two prospective studies that had a follow-up
duration of up to 2 years, both recruited subjects with
diagnoses encompassing a wider spectrum of func-
tional psychoses such as aﬀective disorders (Rund
et al. 2007) and other non-aﬀective psychoses includ-
ing delusional disorder and brief psychotic disorder
(Addington et al. 2004 ; Rund et al. 2007) in comparison
with a more narrowly deﬁned schizophrenia-
spectrum disorder that was examined in our study. In
addition, a cohort of one study had a relatively short
median DUP [8 weeks in Rund et al. (2007) v. 26 weeks
in Addington et al. (2004) and 180 days in this study],
which may minimize the likelihood of observing an
association between DUP and cognitive outcomes.
Concerning the relationship of prolonged DUP to
worse cognitive outcomes, one possible explanation is
that DUP may be biologically deleterious to the brain
(Wyatt, 1991). There is evidence that indicates that a
longer DUP is linked to greater grey matter volume
reductions (Keshavan et al. 1998 ; Lappin et al. 2006 ;
Bangalore et al. 2009 ; Malla et al. 2011), including the
hippocampus (Ebdrup et al. 2010 ; Penttila et al. 2010), a
brain region that is critically involved in the memory
system (Tulving & Markowitsch, 1998). Thus, it is
plausible that a prolonged DUP may result in greater
brain structural deﬁcits with consequently more pro-
nounced cognitive dysfunction. Nonetheless, it should
be noted that results regarding the impact of DUP on
brain morphology remain unclear, with some studies
failing to ﬁnd such a relationship (Hoﬀ et al. 2000 ;
Ho et al. 2003 ; Boonstra et al. 2011). More research
should therefore be conducted to clarify the relation-
ship between DUP and brain structural abnormalities.
Alternatively, DUP may be an epiphenomenon of
prognostic factors and a marker of a subset of schizo-
phrenia patients having poor clinical and cognitive
outcomes (McGlashan, 1999). However, in the current
analysis, potential confounding eﬀects of pre-morbid
adjustment and sex were adjusted and the two DUP
groups showed no signiﬁcant diﬀerence in current
intelligence quotient (IQ) estimate. Further, the pos-
tulation that greater cognitive impairment may lead
to protracted DUP via delayed eﬀective help-seeking
(Lappin et al. 2007) could not account for our ﬁndings
of signiﬁcant association between DUP and longi-
tudinal cognitive outcome as the two DUP groups did
not diﬀer in most cognitive measures at baseline.
The study results have to be interpreted consider-
ing the following methodological limitations. First,
measurement of DUP is inherently retrospective, with
potential recall bias. We employed a structured inter-
view incorporating multiple sources of information
from patients, relatives and medical records to im-
prove the reliability of DUP assessment. Second,
cumulative active positive symptoms after treatment
initiation were not measured in this study. However,
unresolved positive symptoms may contribute to
worse outcomes on negative symptoms and cognition,
as recent studies have revealed that a longer duration
of active psychosis (including both DUP and length of
active psychotic state during treatment) is associated
with larger grey matter volume reduction and ven-
tricular enlargement (Cahn et al. 2009). Third, our ﬁnal
sample comprised slightly more females than males,
which was contrary to many (Marshall et al. 2005), but
not all ﬁrst-episode studies (Oosthuizen et al. 2005 ;
Ucok et al. 2006) showing male preponderance, and
thus may limit the generalizability of our results. One
possible reason was that we recruited patients aged
from 18 to 55 years with a relatively older mean age
of entry (31.2 years) ; therefore it may be more likely
for female schizophrenia patients to be included in
our study as the literature shows that females have an
older age of illness onset than males and a second
(though smaller) peak age of onset in their 40s (Ha¨fner
et al. 1993 ; Castle et al. 1998). Fourth, healthy controls
were assessed once at baseline without being followed
up in parallel with schizophrenia patients for 3 years ;
thus the magnitude of practice eﬀect on trajectories of
cognitive functions could not be addressed in this
study. Fifth, the number of subjects included in this
study was modest and the drop-out rate of 29% may
compromise the validity of our results. The potential
attrition bias may partly be minimized by the lack
of signiﬁcant diﬀerences between completers and
non-completers with regard to sociodemographics,
psychopathological scores and cognitive functions at
baseline. Our drop-out rate was also comparable with
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that of several previous longitudinal ﬁrst-episode
studies (approximately 25–35% within 1 to 4 years
of follow-up; Harrigan et al. 2003 ; Clarke et al. 2006 ;
Jeppensen et al. 2008). Nonetheless, replication by
further studies with a larger sample size is warranted
to conﬁrm our ﬁndings of an independent contri-
bution of DUP to cognitive outcome.
In conclusion, our results provided further sup-
portive evidence that prolonged DUP is associated
with worse outcomes on cognition and negative
symptoms in the early phase of schizophrenia even
when potential confounders including pre-morbid
adjustment are controlled for. Length of untreated in-
itial psychosis was found to exert diﬀerential eﬀects on
various cognitive domains, with deﬁcits in memory
function being most related to DUP. The impact of
DUP on memory dysfunction, particularly verbal
memory impairment, may only become evident at a
later stage of recovery from the ﬁrst psychotic episode.
Owing to limited data on the relationship between
DUP and cognitive impairment, more prospective re-
search with longer follow-up duration should be con-
ducted to clarify whether treatment delay in the ﬁrst
psychotic episode independently predicts longitudi-
nal cognitive outcomes.
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